“…Several studies have analyzed the pharmacodynamics and safety of Asfotase alfa and additionally shown its positive effects on survival rates, dental health, skeletal development, motor functions, and respiratory functions in mouse models and HPP patients [ 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 ]. Furthermore, treatment of HPP patients with a sclerostin antibody and the osteoporosis medication teriparatide have already been described, but these approaches primarily target bone mass and fracture healing rather than substituting or supporting TNAP activity [ 63 , 64 , 65 , 66 , 67 , 68 , 69 ].…”